Publisher Correction: Rapid endothelial cytoskeletal reorganization enables early blood–brain barrier disruption and long-term ischaemic reperfusion brain injury (Nature Communications, (2016), 7, 1, (10523), 10.1038/ncomms10523);Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury

Nature Communications

Volumn 7, Issue , 2016, Pages

  Shi, Yejie ^a,b   Zhang, Lili ^a,c,d   Pu, Hongjian ^a,c   Mao, Leilei ^a,c   Hu, Xiaoming ^a,c,d   Jiang, Xiaoyan ^a,c   Xu, Na ^c   Stetler, R Anne ^a,c,d   Zhang, Feng ^a,c,d   Liu, Xiangrong ^a,b   Leak, Rehana K ^e   Keep, Richard F ^f   Ji, Xunming ^b   Chen, Jun ^a,c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e DUQUESNE UNIVERSITY   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN DEPOLYMERIZING FACTOR; GELATINASE B; ACTIN;

BLOOD; BRAIN; CELLS AND CELL COMPONENTS; ENZYME ACTIVITY; INJURY; NEUROLOGY; POLYMERIZATION;

ACTIN POLYMERIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN INJURY; BRAIN ISCHEMIA; CAPILLARY ENDOTHELIAL CELL; CELL DAMAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CYTOSKELETON; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; REPERFUSION INJURY; ANIMAL; CHEMISTRY; ENDOTHELIUM CELL; GENETICS; HUMAN; MALE; METABOLISM; POLYMERIZATION;

ACTINS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CYTOSKELETON; ENDOTHELIAL CELLS; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICE; POLYMERIZATION; REPERFUSION INJURY;

EID: 84955446823     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-020-18263-5     Document Type: Erratum

References (67)

1. Neuwelt, E. A. et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat. Rev. Neurosci. 12, 169-182 (2011).
2. Khatri, R., McKinney, A. M., Swenson, B., Janardhan, V. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute stroke. Neurology 79, S52-S57 (2012).
3. Neumann-Haefelin, T. et al. Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation. Stroke 31, 1965-1972 (2000).
4. Olah, L., Wecker, S., Hoehn, M. Secondary deterioration of apparent diffusion coefficient after 1-hour transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 20, 1474-1482 (2000).
5. Kaur, J. et al. Quantified T1 as an adjunct to apparent diffusion coefficient for early infarct detection: a high-field magnetic resonance study in a rat stroke model. Int. J. Stroke 4, 159-168 (2009).
6. Amantea, D. et al. Rational modulation of the innate immune system for neuroprotection in ischemic stroke. Front. Neurosci. 9, 147 (2015).
7. Rodrigues, S. F., Granger, D. N. Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure. Cardiovasc. Res. 87, 291-299 (2010).
8. Liu, J., Jin, X., Liu, K. J., Liu, W. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J. Neurosci. 32, 3044-3057 (2012).
9. Asahi, M. et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 1681-1689 (2000).
10. del Zoppo, G. J. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience 158, 972-982 (2009).
11. Dimitrijevic, O. B., Stamatovic, S. M., Keep, R. F., Andjelkovic, A. V. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemiareperfusion injury. J. Cereb. Blood Flow Metab. 26, 797-810 (2006).
12. Gorina, R., Lyck, R., Vestweber, D., Engelhardt, B. beta2 integrin-mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood-brain barrier. J. Immunol. 192, 324-337 (2014).
13. Wallez, Y., Huber, P. Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim. Biophys. Acta 1778, 794-809 (2008).
14. Endres, M. et al. Neuroprotective effects of gelsolin during murine stroke. J. Clin. Invest. 103, 347-354 (1999).
15. Burridge, K., Wittchen, E. S. The tension mounts: stress fibers as forcegenerating mechanotransducers. J. Cell Biol. 200, 9-19 (2013).
16. Vandenbroucke, E., Mehta, D., Minshall, R., Malik, A. B. Regulation of endothelial junctional permeability. Ann. NY Acad. Sci. 1123, 134-145 (2008).
17. Mehta, D., Malik, A. B. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86, 279-367 (2006).
18. Stamatovic, S. M. et al. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 25, 593-606 (2005).
19. Asahi, M. et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724-7732 (2001).
20. Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., Rosenberg, G. A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27, 697-709 (2007).
21. Heo, J. H. et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 624-633 (1999).
22. Zhao, B. Q. et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 12, 441-445 (2006).
23. Lee, S. R. et al. Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J. Neurosci. 26, 3491-3495 (2006).
24. Seo, J. H. et al. Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury. J. Clin. Invest. 123, 782-786 (2013).
25. Yang, Y. et al. Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery. J. Cereb. Blood Flow Metab. 33, 1104-1114 (2013).
26. Dudek, S. M., Garcia, J. G. Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 91, 1487-1500 (2001).
27. Pellegrin, S., Mellor, H. Actin stress fibres. J. Cell Sci. 120, 3491-3499 (2007).
28. dos Remedios, C. G. et al. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol. Rev. 83, 433-473 (2003).
29. Allen, C., Srivastava, K., Bayraktutan, U. Small GTPase RhoA and its effector rho kinase mediate oxygen glucose deprivation-evoked in vitro cerebral barrier dysfunction. Stroke 41, 2056-2063 (2010).
30. Li, G. et al. Permeability of endothelial and astrocyte cocultures: In vitro blood-brain barrier models for drug delivery studies. Ann. Biomed. Eng. 38, 2499-2511 (2010).
31. Koni, P. A. et al. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J. Exp. Med. 193, 741-754 (2001).
32. Li, P. et al. Adoptive regulatory T-cell therapy protects against cerebral ischemia. Ann. Neurol. 74, 458-471 (2013).
33. Vandooren, J., Geurts, N., Martens, E., Van den Steen, P. E., Opdenakker, G. Zymography methods for visualizing hydrolytic enzymes. Nat. Methods 10, 211-220 (2013).
34. Cauwe, B., Martens, E., Proost, P., Opdenakker, G. Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates. Integr. Biol. (Camb) 1, 404-426 (2009).
35. Cauwe, B., Opdenakker, G. Intracellular substrate cleavage: A novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 45, 351-423 (2010).
36. Stamatovic, S. M., Keep, R. F., Wang, M. M., Jankovic, I., Andjelkovic, A. V. Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J. Biol. Chem. 284, 19053-19066 (2009).
37. Prasain, N., Stevens, T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc. Res. 77, 53-63 (2009).
38. Shasby, D. M., Shasby, S. S., Sullivan, J. M., Peach, M. J. Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ. Res. 51, 657-661 (1982).
39. Franke, R. P. et al. Induction of human vascular endothelial stress fibres by fluid shear stress. Nature 307, 648-649 (1984).
40. Suurna, M. V. et al. Cofilin mediates ATP depletion-induced endothelial cell actin alterations. Am. J. Physiol. Renal Physiol 290, F1398-F1407 (2006).
41. Bamburg, J. R., Wiggan, O. P. ADF/cofilin and actin dynamics in disease. Trends Cell Biol. 12, 598-605 (2002).
42. Pritchard, C. A. et al. B-Raf acts via the ROCKII/LIMK/cofilin pathway to maintain actin stress fibers in fibroblasts. Mol. Cell Biol. 24, 5937-5952 (2004).
43. Knowland, D. et al. Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke. Neuron 82, 603-617 (2014).
44. Iadecola, C., Anrather, J. The immunology of stroke: From mechanisms to translation. Nat. Med. 17, 796-808 (2011).
45. Moskowitz, M. A., Lo, E. H., Iadecola, C. The science of stroke: mechanisms in search of treatments. Neuron 67, 181-198 (2010).
46. Stamatovic, S. M., Keep, R. F., Andjelkovic, A. V. Brain endothelial cell-cell junctions: How to 'open' the blood brain barrier. Curr. Neuropharmacol. 6, 179-192 (2008).
47. Dimitrijevic, O. B., Stamatovic, S. M., Keep, R. F., Andjelkovic, A. V. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38, 1345-1353 (2007).
48. Jin, A. Y. et al. Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: A future therapeutic target for treatment of stroke. BMC Neurosci. 11, 12 (2010).
49. Kitagawa, K. et al. Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 18, 1336-1345 (1998).
50. Agrawal, S. et al. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med. 203, 1007-1019 (2006).
51. Justicia, C. et al. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J. Cereb. Blood Flow Metab. 23, 1430-1440 (2003).
52. Ludewig, P. et al. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke. Circ. Res. 113, 1013-1022 (2013).
53. Gidday, J. M. et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol. 289, H558-H568 (2005).
54. Song, J. et al. Focal MMP-2 and MMP-9 activity at the blood-brain barrier promotes chemokine-induced leukocytemigration. Cell Rep. 10, 1040-1054 (2015).
55. Bolton, S. J., Anthony, D. C., Perry, V. H. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86, 1245-1257 (1998).
56. Iadecola, C., Anrather, J. Stroke research at a crossroad: Asking the brain for directions. Nat. Neurosci. 14, 1363-1368 (2011).
57. Mooradian, A. D. Effect of aging on the blood-brain barrier. Neurobiol. Aging 9, 31-39 (1988).
58. Barber, P. A., Demchuk, A. M., Zhang, J., Buchan, A. M. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta stroke programme early CT score. Lancet 355, 1670-1674 (2000).
59. Kaur, J., Tuor, U. I., Zhao, Z., Barber, P. A. Quantitative MRI reveals the elderly ischemic brain is susceptible to increased early blood-brain barrier permeability following tissue plasminogen activator related to claudin 5 and occludin disassembly. J. Cereb. Blood Flow Metab. 31, 1874-1885 (2011).
60. Stetler, R. A. et al. Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling. J. Neurosci. 28, 13038-13055 (2008).
61. Fisher, M. et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40, 2244-2250 (2009).
62. Leak, R. K. et al. HSP27 protects the blood-brain barrier against ischemiainduced loss of integrity. CNS Neurol. Disord. Drug Targets 12, 325-337 (2013).
63. Chen, J. et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18, 4914-4928 (1998).
64. Costes, S. V. et al. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 86, 3993-4003 (2004).
65. Yin, K. J. et al. Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J. Neurosci. 30, 6398-6408 (2010).
66. Hue, C. D. et al. Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein. J. Cereb. Blood Flow Metab. 35, 1191-1198 (2015).
67. Cao, G. et al. Intracellular Bax translocation after transient cerebral ischemia: Implications for a role of the mitochondrial apoptotic signaling pathway in ischemic neuronal death. J. Cereb. Blood Flow Metab. 21, 321-333 (2001).